News Releases

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
5/15/2017
4:05 PM ET
Earnings Release

Diffusion Pharmaceuticals Provides Corporate Highlights and Reports Financial First Quarter 2017 Results

5/15/2017

CHARLOTTESVILLE, Va., May 15, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therape...

 Continue Reading
4/4/2017
8:41 AM ET
Press Release

Diffusion Pharmaceuticals Awarded U.S. Patent for TSC as Therapeutic in Five Hypoxia-Related Indications

4/4/2017

CHARLOTTESVILLE, Va., April 04, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule thera...

 Continue Reading
4/3/2017
8:30 AM ET
Press Release

Diffusion Pharmaceuticals Announces Closing of Oversubscribed Private Placement

4/3/2017

CHARLOTTESVILLE, Va., April 03, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule thera...

 Continue Reading
3/31/2017
8:30 AM ET
Earnings Release

Diffusion Pharmaceuticals Provides Corporate Highlights and Reports 2016 Financial Results

3/31/2017

CHARLOTTESVILLE, Va., March 31, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule thera...

 Continue Reading
2/8/2017
8:00 AM ET
Press Release

Diffusion Pharmaceuticals’ TSC Phase 1/2 Glioblastoma Multiforme Clinical Trial Results Published in February 2017 Edition of Journal of Neurosurgery

2/8/2017

CHARLOTTESVILLE, Va., Feb. 08, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therap...

 Continue Reading
12/12/2016
8:30 AM ET
Press Release

Diffusion Pharmaceuticals Files Definitive Proxy Statement for Upcoming Special Meeting of Stockholders

12/12/2016

CHARLOTTESVILLE, Va., Dec. 12, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therap...

 Continue Reading
Displaying 1 to 7 (of 75 releases)